Skip Navigation


BJA Advance Access originally published online on July 23, 2009
British Journal of Anaesthesia 2009 103(4):554-560; doi:10.1093/bja/aep199
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
103/4/554    most recent
aep199v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tolchard, S.
Right arrow Articles by Fitzjohn, S. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tolchard, S.
Right arrow Articles by Fitzjohn, S. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Author [2009]. Published by Oxford University Press on behalf of The Board of Directors of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournal.org

Hypothermic responses to infection are inhibited by {alpha}2-adrenoceptor agonists with possible clinical implications

S. Tolchard1,2,*, P. A. Burns4,5, D. J. Nutt3 and S. M. Fitzjohn2

1 Department of Anaesthesia, Frenchay Hospital, North Bristol NHS Trust, Frenchay, Bristol, UK.
2 Department of Anatomy and
3 Psychopharmacology Unit, University of Bristol, UK.
4 Department of Medicine, United Bristol Healthcare Trust, Bristol Royal Infirmary, Bristol, UK.

* Corresponding author. E-mail: stevetolchard{at}yahoo.co.uk

Background: {alpha}2-Adrenoceptor agonists are currently used as primary sedative agents in high dependency patients who are at high risk of sepsis. Clinical surveillance of such patients relies in part on their ability to mount appropriate responses to infection, in particular thermal responses. Thermoregulatory responses to infection are well studied in the rat and in this species, and humans, infection can induce febrile, hypothermic, or mixed hypothermic and febrile responses. The involvement of noradrenergic systems in thermal responses to infection prompted the hypothesis that ligands that act on adrenoceptors may interfere with the normal thermal responses to infection.

Methods: In this study on rats, the effect of infusion of the selective {alpha}2-agonist, mivazerol, on hypothermic and plasma corticosterone responses induced by bacterial lipopolysaccharide (LPS) was investigated.

Results: Clinically effective doses of mivazerol (4.8 and 10 µg kg–1 h–1) had no effect on body temperature alone. However, mivazerol significantly inhibited the typical thermoregulatory response to bacterial LPS in a dose-dependent manner. This effect was mimicked by the selective {alpha}2-agonist, UK14304-18 (6 µg kg–1 h–1), and antagonized by the {alpha}2-antagonist, RX811059A (7 µg kg–1 h–1). The {alpha}2-ligands had no effect on basal or LPS-induced corticosterone levels.

Conclusions: These data suggest that early thermoregulatory responses to infection can be selectively antagonized by ligands that activate {alpha}2-adrenoreceptors. High dependency patients receiving {alpha}2-adrenoceptor agonists may not be capable of mounting a normal thermal response to infecting organisms and clinical monitoring using core temperature to detect infection may therefore be unreliable in these vulnerable patients.

Keywords: adrenergic receptors; bacterial infection; temperature


5 Present address: The Orchard Medical Centre, Macdonald Walk, Kingswood, Bristol BS15 8NJ, UK


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.